Santa Cruz Biotechnology

Santa Cruz Biotechnology is focused on the ongoing development of research antibodies, with a goal of offering the broadest range of research reagents in the field. The company offers more than 2,850 target-specific 19-25 nucleotide siRNAs that can be used to knockdown protein expression in a broad variety of mammalian cell types. Its primary product line includes siRNAs designed to silence a large selection of proteins including tumor suppressors, kinases, transcription regulators, cell cycle proteins, membrane receptors, kinases, signaling intermediates, cell adhesion proteins and proteins involved in lymphocyte signaling. The company s secondary product line provides a new method for the detection of immunoprecipitated proteins via western blot analysis. Santa Cruz Biotechnology offers online ordering for all its products. The company is headquartered in Santa Cruz, Calif.